Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2	2026-06-23		NCT05609578

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Mirati Therapeutics Inc.	14

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials